Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Double-Blind Method Neoplasms -- drug therapy Placebos Randomized Controlled Trials as Topic -- standards Single-Blind Method Antineoplastic Agents Biological Products Randomized Controlled Trials as Topic -- ethics Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (3 pages)).
- NLM Unique ID:
- 101760343 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101760343